|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Receivables, net | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Income Taxes Receivable | ||||||||||||||||||||
| Other | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Accounts Receivable, Allowance for Credit Loss, Noncurrent | ||||||||||||||||||||
| Preneed receivables, net and trust investments | ||||||||||||||||||||
| Financing Receivable, Allowance for Credit Loss, Noncurrent | ||||||||||||||||||||
| Cemetery property | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Deferred charges and other assets | ||||||||||||||||||||
| Cemetery perpetual care trust investments | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES & EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Current maturities of long-term debt | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Deferred preneed revenue | ||||||||||||||||||||
| Deferred Income Taxes and Other Tax Liabilities, Noncurrent | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Deferred receipts held in trust | ||||||||||||||||||||
| Care trusts’ corpus | ||||||||||||||||||||
| Common stock, shares authorized | ||||||||||||||||||||
| Common stock, shares outstanding | ||||||||||||||||||||
| Equity: | ||||||||||||||||||||
| Common Stock, Value, Outstanding | ||||||||||||||||||||
| Capital in excess of par value | ||||||||||||||||||||
| Retained Earnings (Accumulated Deficit) | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Total common stockholders’ equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Common stock, par or stated value per share | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
| Accounts Receivable, Allowance for Credit Loss | ||||||||||||||||||||
| Common stock, shares, issued | ||||||||||||||||||||
| Allowance for credit losses for Deferred charges and other assets |
Loading...
